MARATTO

article · Neurological Research

Pattern of anti-seizure medications and predictors of depression in people with epilepsy

Abstract

METHOD: This cross-sectional study recruited 940 PWE attending outpatient clinics of selected tertiary hospitals in southwestern Nigeria, with diagnosis confirmed clinically and supported by electroencephalography (EEG), aged ≥15 years, with no history of psychogenic non-epileptic seizures. Zung Self-Rating Depression Score (ZSRDS) was used to assess depression, and Liverpool Adverse Event Profile (LAEP) was used to assess the adverse effects of ASM. RESULTS: < 0.001). CONCLUSION: While depression is prevalent among PWE, adverse events, non-use of ASM, and duration of ASM use were among the predictors of depression. Health care providers should work towards preventing adverse events and achieving early seizure control with appropriate pharmacotherapeutic intervention.

Research topics

  • Epilepsy research and treatment
  • Pharmacological Effects and Toxicity Studies
  • Neuroscience and Neuropharmacology Research

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1080/01616412.2025.2571953

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.